TREACE MED CONCEPTS INC shareholders Q2 2023

TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 139 filers reported holding TREACE MED CONCEPTS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

TREACE MED CONCEPTS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Aquatic Capital Management LLC 19,000$4860.03%
ARCADIA INVESTMENT MANAGEMENT CORP/MI 3,707$94,8260.02%
Calamos Advisors LLC 154,074$3,941,2120.02%
GABELLI FUNDS LLC 76,293$1,951,5750.02%
Sandia Investment Management LP 2,500$63,9500.01%
Russell Investments Group, Ltd. 283,191$7,244,0240.01%
Candriam S.C.A. 70,000$1,790,6000.01%
Trexquant Investment LP 16,582$424,1680.01%
SEI INVESTMENTS CO 214,141$5,477,7270.01%
PUTNAM INVESTMENTS LLC 269,288$6,888,3870.01%
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 92,000$2,353,3600.01%
TD Capital Management LLC 2,490$63,6940.01%
TWO SIGMA INVESTMENTS, LP 110,305$2,821,6020.01%
Cubist Systematic Strategies, LLC 42,744$1,093,3920.01%
Connor, Clark & Lunn Investment Management Ltd. 50,920$1,302,5340.01%
CAPTRUST FINANCIAL ADVISORS 54,793$1,401,6050.01%
Qube Research & Technologies Ltd 65,090$1,665,0020.01%
D. E. Shaw & Co., Inc. 240,963$6,163,8340.01%
MetLife Investment Management, LLC 24,068$615,6590.01%
Walleye Capital LLC 51,600$1,319,9280.01%
External links

This page lists TREACE MED CONCEPTS INC's shareholders in Q2 2023. To view TREACE MED CONCEPTS INC's shareholder history, click here.